To celebrate World Amyloidosis Day on October 26 the AAN is offering separate virtual education programs for Patients and Families and Doctors and Health Professionals.

These sessions are scheduled for:

• Patients and Families – Saturday October 26, 1pm
  
• Doctors and Health Professionals – Thursday October 31, 3pm

The registration form will be accessible on this page from October 14 through to October 29.

Virtual Health Professionals Event – Thursday, October 31 – PROGRAM

Bios:

A/Prof James Hare is a Cardiologist in Heart Failure and Transplantation and Head of Non-Invasive Cardiac Imaging at The Alfred Hospital in Melbourne. He completed his PhD in advanced echocardiography at the University of Queensland and then undertook a post-doctoral fellowship in Cardiac MRI at the Libin Cardiovascular Institute, University of Calgary, Alberta, Canada. He has active research interests in heart failure and cardiac imaging and is an Associate Professor (Clinical Adjunct) at Monash University, Melbourne. James has specific expertise in diagnosis and management of inflammatory and infiltrative cardiomyopathies and directs the Cardiac Amyloidosis Clinic at The Alfred.

Dr Olga Motorna is a clinical haematologist and Myeloma Lead in Box Hill Hospital and an Acting Director of the Victorian and Tasmanian Amyloidosis Service (VTAS). She obtained Bachelor of Science in Biology from Hope College in Michigan, and following a year of basic science research at the Van Andel Cancer Research Institute, she moved to Ireland where she completed her medical studies at Trinity College Dublin. She relocated to Melbourne in 2012 and underwent her physician training and haematology advanced training at Monash Health and the Alfred Hospital. She is currently finishing her PhD studies at the Peter MacCallum Cancer Centre where she is elucidating mechanisms of epigenetic regulation in multiple myeloma. She is a recipient of NHMRC Scholarship and HSANZ New Investigator Scholarship. She is passionate about patient-centered care and bringing clinical trials to patients with myeloma and amyloidosis to improve their access to most effective therapy. She is a principal investigator on numerous trials currently open at Box Hill Hospital.

Dr Antonia Carroll is a neurologist, neurophysiologist and clinician-researcher with specific interests in neuromuscular neurology and neuro-haematology. She is the Director of Neurophysiology, Neurology Lead of the Amyloidosis Centre and Staff Specialist at St Vincent’s Hospital in Sydney, Australia. Dr Carroll is the Neurology Lead at the Westmead Amyloidosis Service, Sydney. She is a committee member of the Australian Amyloidosis Network and the Neuromuscular Society of Australia and New Zealand.

Dr Carroll received her medical degree from the University of Sydney and completed neurology training in Sydney at Royal Prince Alfred, Concord and St Vincent’s Hospitals. In 2017, she was awarded an Australian and New Zealand Association of Neurology (ANZAN) fellowship to the National Hospital for Neurology and Neurosurgery, Queen Square, London, where she developed expertise in the investigation and management of neuromuscular and neuro-haematological disorders. Dr Carroll has completed further sub-specialty training in neuromuscular disease and neurophysiology. She has undertaken an internationally collaborative PhD between the Brain and Mind Centre, University of Sydney, and Queen Square Centre for Neuromuscular Diseases, University College London, UK. Her PhD research has investigated diagnostic strategies and early disease biomarkers in amyloid and paraproteinaemic neuropathies and neuro-haematological disorders.